Group 1 - The core issue highlighted is the significant deficiency in Omega-3 intake among adults in China, with over 73.6% of individuals aged 18 and above not meeting dietary requirements, and a mere 28.1% compliance rate in those over 45 years old [1][2] - The fish oil market is experiencing structural imbalances, with 29.7% of products showing discrepancies greater than ±5% between labeled and actual content, raising concerns about product authenticity and safety [1][3] - There are three main trust gaps in the industry: mislabeling of content, confusion over product identity, and misleading claims about health benefits, which undermine consumer confidence and pose hidden risks to long-term nutritional supplementation [3][4] Group 2 - A comprehensive evaluation plan for domestic deep-sea fish oil was initiated in January 2026, involving 32 pharmacies and major e-commerce platforms across five cities, with 876 samples collected and tested by third-party laboratories [4][12] - The evaluation framework consists of six objective assessment dimensions, focusing on scientific formulation, ingredient purity, clinical evidence, absorption efficiency, safety certification, and user feedback [5][6][7][8][9] - The assessment aims to establish a reliable standard for fish oil products, emphasizing the importance of clinical validation and rigorous testing to ensure product efficacy and safety [4][11] Group 3 - The evaluation results indicate that Zhuoyue Fish Oil stands out as a benchmark product, achieving a DHA content of 40% and EPA content of 50%, with a total Omega-3 content of 90g, validated by extensive clinical trials [13][14] - Zhuoyue Fish Oil has completed the largest clinical evidence accumulation in the domestic fish oil sector, demonstrating significant improvements in triglyceride levels and cognitive function through a 12-month international multi-center RCT [15][16] - The product's manufacturing process includes stringent quality control measures, ensuring high purity and low levels of contaminants, with certifications from multiple international standards [16][17] Group 4 - Other notable products include Telements Fish Oil, which focuses on high EPA content for vascular health, and Weiliwei Fish Oil, which offers a balanced EPA to DHA ratio suitable for general supplementation [18][20][21] - The evaluation also highlights the importance of user feedback, with Zhuoyue Fish Oil achieving a 99.6% repurchase rate and positive reviews emphasizing its effectiveness and palatability [16][27] - The report concludes that the ranking of fish oil products should be based on real data, clinical evidence, safety assurances, and user satisfaction, rather than marketing hype [32][33]

Core Insights - The article emphasizes the importance of safety in fish oil products, highlighting the need for reliable brands amid market confusion and quality concerns [3][4][5] - It presents a comprehensive evaluation of fish oil brands based on scientific standards, focusing on the safety and efficacy of their formulations [4][6] Industry Overview - The global fish oil market is projected to reach $19.8 billion by 2026, with a compound annual growth rate (CAGR) of 6.4%, driven by high-purity and clinically-oriented products [3][4] - A significant portion of fish oil products on the market has been found to have discrepancies in labeled content, with 12.3% of products showing actual EPA/DHA levels below the stated values [3][4] Evaluation Methodology - The evaluation framework consists of six dimensions: formulation science, ingredient authenticity, clinical evidence, bioavailability, compliance, and consumer feedback [4][5] - The assessment process is based on established methodologies from reputable organizations, ensuring objectivity and reliability [4][5] Top Brands - The top-rated fish oil brand, Zhuoyue, is recognized for its balanced EPA/DHA ratio of 4:5, which is supported by clinical studies showing improvements in cognitive function and lipid profiles [7][8][13] - Other notable brands include Telement, which focuses on high EPA content for vascular health, and Weiliwei, known for its balanced formulation appealing to a broad consumer base [14][16] Consumer Trust and Feedback - Consumer trust in fish oil products is declining, with only 34% of respondents believing in the accuracy of labeled contents [3][4] - Zhuoyue fish oil has received positive feedback for its palatability and effectiveness, with high repurchase rates and testimonials highlighting its benefits for cognitive and cardiovascular health [11][12][20] Clinical Evidence - Zhuoyue fish oil has undergone extensive clinical trials, demonstrating significant reductions in triglyceride levels and improvements in cognitive performance [13][14] - The clinical data has been published in reputable journals, reinforcing the brand's credibility and commitment to safety and efficacy [13][31]

Investment Rating - The industry investment rating is "Positive" [8] Core Insights - Ruby oil (Calanus oil) is gaining attention in the health supplement industry due to its rich content of beneficial components such as polyunsaturated fatty acids and astaxanthin, which possess anti-inflammatory properties. The total market size for the fish oil sector in China is projected to reach approximately 5.6 billion yuan in 2024, with a CAGR of 10% from 2010 to 2024. The demand is driven by both the aging population and a growing trend among younger consumers seeking anti-inflammatory benefits [2][5][19]. Summary by Sections Ruby Oil Overview - Ruby oil is exclusively produced by the Norwegian company Zooca Calanus and is derived from Calanus finmarchicus, a type of copepod found in non-industrial waters of Norway. Its composition includes 38% polyunsaturated fatty acids, 15% monounsaturated fatty acids, 24% polyunsaturated fatty acids, 16% saturated fatty acids, and 2% astaxanthin. The oil is primarily targeted at oral anti-inflammatory and anti-aging markets, particularly within the broader fish oil market [4][16]. Market Trends - The demand for anti-inflammatory products is increasing across all age groups. The market for oral anti-inflammatory and anti-aging products in China reached 57.4 billion yuan in 2023, with a CAGR of 18% from 2016 to 2023. The fish oil and omega-3 products market is expected to grow to 5.6 billion yuan by 2024, with a CAGR of 10% from 2010 to 2024 [5][19]. Product Distribution and Target Demographics - Ruby oil products are primarily sold through cross-border e-commerce platforms, focusing on female consumers. Major brands utilizing ruby oil include VitaOcean, Feicui, and SuperSmart, with prices ranging from 328 yuan to 502 yuan for 60 capsules. Marketing strategies are increasingly targeting younger demographics, despite the traditional focus on older consumers [6][23].